Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy

Andrologia

Volumn 47, Issue 6, 2015, Pages 680-684

  Cunha, F S ^a   Domenice, S ^a   Camara V L ^a   Sircili, M H P ^a   Gooren, L J G ^b,c   Mendonca B B ^a   Costa, E M F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Androconsult   (Thailand)

Author keywords

Cross sex hormone; Hyperprolactinaemia; Male to female transsexual; Oestrogen; Prolactinoma

Indexed keywords

CABERGOLINE; CROSS SEX HORMONE; CYPROTERONE ACETATE; ESTRADIOL; ESTRADIOL 17 BETA ENANTHATE; ESTRADIOL ENANTHATE; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROLACTIN; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ERGOLINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; DRUG MEGADOSE; ESTROGEN THERAPY; FEMALE; GALACTORRHEA; GYNECOMASTIA; HUMAN; MALE; MALE TO FEMALE TRANSGENDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PENIS; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TESTIS; BLOOD; CHEMICALLY INDUCED; PITUITARY NEOPLASMS; TRANSGENDER;

ADULT; ANTINEOPLASTIC AGENTS; ERGOLINES; ESTROGENS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; TRANSGENDER PERSONS;

EID: 84935076763     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/and.12317     Document Type: Article

References (16)

1. Ben-Jonathan N, Hnasko R (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763.
2. Bunck MC, Debono M, Giltay EJ, Verheijen AT, Diamant M, Gooren LJ (2009) Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages. BMJ Case Rep 2009. pii: bcr02.2009.1589.
3. Ciccarelli A, Daly AF, Beckers A (2005) The epidemiology of prolactinomas. Pituitary 8:3-6.
4. Garcia-Malpartida K, Martin-Gorgojo A, Rocha M, Gomez-Balaguer M, Hernandez-Mijares A (2010) Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual. Fertil Steril 94:1097.e13-1097.e15. doi: 10.1016/j.fertnstert.2010.01.076. Epub 2010 Mar 12
5. Gooren LJ (2011) Clinical practice. Care of transsexual persons. N Engl J Med 364:1251-1257.
6. Gooren LJ, Assies J, Asscheman H, de Slegte R, van Kessel H (1988) Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 66:444-446.
7. Gooren LJ, Sungkaew T, Giltay EJ (2013) Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys). Asian J Androl 15:280-285.
8. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132-3154.
9. Kovacs K, Stefaneanu L, Ezzat S, Smyth HS (1994) Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study. Arch Pathol Lab Med 118:562-565.
10. Radl D, De Mei C, Chen E, Lee H, Borrelli E (2013) Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia. Mol Endocrinol 27:953-965.
11. Rotondi NK, Bauer GR, Scanlon K, Kaay M, Travers R, Travers A (2013) Nonprescribed hormone use and self-performed surgeries: 'do-it-yourself' transitions in transgender communities in Ontario, Canada. Am J Public Health 103:1830-1836.
12. Serri O, Noiseux D, Robert F, Hardy J (1996) Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient. J Clin Endocrinol Metab 81:3177-3179.
13. Spady TJ, Pennington KL, McComb RD, Birt DF, Shull JD (1999) Estrogen-induced pituitary tumor development in the ACI rat not inhibited by dietary energy restriction. Mol Carcinog 26:239-253.
14. Strecker TE, Spady TJ, Schaffer BS, Gould KA, Kaufman AE, Shen F, McLaughlin MT, Pennington KL, Meza JL, Shull JD (2005) Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains. Genetics 169:2189-2197.
15. Wendell DL, Pandey J, Kelley P (2002) A congenic strain of rat for investigation of control of estrogen-induced growth. Mamm Genome 13:664-666.
16. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL (1995) Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 80:3621-3627.